Physostigmine Other names: Eserolein methylcarbamate Eserine Eserine sulfate Erserine

Chemical formula: C₁₅H₂₁N₃O₂  Molecular mass: 275.346 g/mol  PubChem compound: 5983

Therapeutic indications

Physostigmine is indicated for:

Indication

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Anticholinergic drug overdose

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only children (1 year - 12 years old)

Anticholinergic drug overdose

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Physostigmine is contraindicated in the following cases:

Contraindication

at least one of
Asthma
Status asthmaticus

DECAMETHONIUM
Suxamethonium
Gangrene and necrosis of lung
Bilateral inguinal hernia, with gangrene
Unilateral or unspecified inguinal hernia, with gangrene
Bilateral femoral hernia, with gangrene
Unilateral or unspecified femoral hernia, with gangrene
Umbilical hernia with gangrene
Ventral hernia with gangrene
Diaphragmatic hernia with gangrene
Other specified abdominal hernia with gangrene
Unspecified abdominal hernia with gangrene
Gangrene, not elsewhere classified
Diabetes mellitus

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2011: ANTICHOLIUM Injection solution
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈